Anti-Jo-1 positive inclusion body myositis with a marked and sustained clinical improvement after oral prednisone

被引：22

作者：

Hengstman, GJD

Ter Laak, HJ

van Engelen, BGM

Van Venrooij, WJ

机构：

[1] Catholic Univ Nijmegen, Med Ctr, Inst Neurol, Neuromuscular Ctr Nijmegen, NL-6500 HB Nijmegen, Netherlands

[2] Univ Nijmegen, Dept Biochem, NL-6500 HD Nijmegen, Netherlands

来源：

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY | 2001年 / 70卷 / 05期

关键词：

D O I：

10.1136/jnnp.70.5.706

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：706 / 706

页数：1

共 6 条

[1]

POLYMYOSITIS, DERMATOMYOSITIS, AND INCLUSION-BODY MYOSITIS [J].

DALAKAS, MC .

NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (21) :1487-1498

[2]

INCLUSION-BODY MYOSITIS AND MYOPATHIES [J].

GRIGGS, RC ;

ASKANAS, V ;

DIMAURO, S ;

ENGEL, A ;

KARPATI, G ;

MENDELL, JR ;

ROWLAND, LP .

ANNALS OF NEUROLOGY, 1995, 38 (05) :705-713

[3]

Presence of the anti-Jo-1 autoantibody excludes inclusion body myositis [J].

Hengstman, GJD ;

van Engelen, BGM ;

Badrising, UA ;

van den Hoogen, FHJ ;

van Venrooij, WJ .

ANNALS OF NEUROLOGY, 1998, 44 (03) :423-423

[4]

Koffman BM, 1998, MUSCLE NERVE, V21, P115, DOI 10.1002/(SICI)1097-4598(199801)21:1<115::AID-MUS15>3.3.CO

[5]

2-G

[6]

Anti-Ro52 antibodies frequently co-occur with anti-Jo-1 antibodies in sera from patients with idiopathic inflammatory myopathy [J].

Rutjes, SA ;

Egberts, WTMV ;

Jongen, P ;

VandenHoogen, F ;

Pruijn, GJM ;

VanVenrooij, WJ .

CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1997, 109 (01) :32-40

← 1 →